Similarly, when the gene expression levels of CDK1, CDK2, CDK4, and CDK6 increased by one transcript per million, the prevalence of CRC increased by 1.15, 0.96, 2.15, and 1.47 times, respectively. This evidence concerns the gene CDK4 and colorectal carcinoma.